GoHealth extends CEO Kotte's contract to 2028; $1M salary, $5M equity, $3M cash retention

GoHealth, Inc.

CEO term extended to April 1, 2028; base salary raised to $1M per year.
2025 annual equity grant of $5M in RSUs vesting over 3 years (185k shares now, remainder pending shareholder approval).
Separate retention award: 500k immediate-vest RSUs and $3M cash ($1.5M now, $1.5M by Jan 2026 tied to performance).
Severance benefits now include death; Change in Control definition expanded to include going-private transactions.
Retention award subject to pro-rata clawback if CEO voluntarily leaves before three-year anniversary.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.